Shionogi applies for HIV drug approval in U.S., Europe

TOKYO, Dec 18 (Reuters) – Japan’s Shionogi & Co said on Tuesday that it has applied to health regulators in theUnited States, Canada and Europe for approval of its HIV drugDolutegravir.Shionogi developed …
Sexual Health News Headlines – Yahoo! News